Cost-Effectiveness of HIV Treatment as Prevention in Serodiscordant Couples
Author(s) -
Rochelle P. Walensky,
Eric L. Ross,
Nagalingeswaran Kumarasamy,
Robin Wood,
Farzad Noubary,
A. David Paltiel,
Yoriko Nakamura,
Sheela Godbole,
Ravindre Panchia,
Ian Sanne,
Milton C. Weinstein,
Elena Losina,
Kenneth H. Mayer,
Ying Qing Chen,
Lei Wang,
Marybeth McCauley,
Theresa Gamble,
George R. Seage,
Myron S. Cohen,
Kenneth A. Freedberg
Publication year - 2013
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmsa1214720
Subject(s) - serodiscordant , human immunodeficiency virus (hiv) , antiretroviral therapy , medicine , cost effectiveness , immunology , viral load , risk analysis (engineering)
The cost-effectiveness of early antiretroviral therapy (ART) in persons infected with human immunodeficiency virus (HIV) in serodiscordant couples is not known. Using a computer simulation of the progression of HIV infection and data from the HIV Prevention Trials Network 052 study, we projected the cost-effectiveness of early ART for such persons.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom